←
Pulse Biosciences91 posts
Pulse Biosciences avatar

Pulse Biosciences

@Pulse_Bio

Powering the next generation in bioelectric medicine with Nanosecond Pulsed Field Ablation technology

◷ Joined February 2020▧ 65 Photos and videos
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 21

The nPulse Vybrance Percutaneous Electrode System (Percutaneous Electrode) is not indicated for use in cardiac procedures. The nPulse Vybrance Percutaneous Electrode System is FDA Cleared for use in the US. FDA 510(k) clearance: K233705, K240782.

Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 21

Indications for Use: The nPulse Vybrance Percutaneous Electrode System is indicated for ablation of soft tissue in percutaneous, and intraoperative surgical procedures.

Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 21

"I didn't want to be on medication the rest of my life." Learn why Astra and her doctor chose a nonsurgical option for benign nodules, and discover the groundbreaking tech behind Nanosecond Pulsed Field Ablation (nsPFA™) energy, now known as nPulse™ Vybrance™ technology: ow.ly/oNGH50Y0nvY

1:05
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 13

During #ThyroidAwarenessMonth and throughout the year, Pulse Biosciences strives to support those affected by thyroid-related diseases and thyroid cancer. Join us in recognizing the strength and resilience of those affected and their loved ones.

0:06
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 5

The nPulse Vybrance Percutaneous Electrode System (Percutaneous Electrode) is not indicated for use in cardiac procedures. The nPulse Vybrance Percutaneous Electrode System is FDA Cleared for use in the US. FDA 510(k) clearance: K233705, K240782.

Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 5

Indications for Use: The nPulse Vybrance Percutaneous Electrode System is indicated for ablation of soft tissue in percutaneous, and intraoperative surgical procedures.

Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·Jan 5

DYK? nPulse™ technology non-thermally eliminates cells while sparing collagen, extracellular matrix, and other adjacent non-cellular tissue through Nanosecond Pulsed Field Ablation (nsPFA™) energy. Learn more at our website: ow.ly/VJxc50XNQqi

1:10
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·7 Oct 2025

We’ve demonstrated the amazing power of nanosecond pulsed field ablation (nsPFA™), now with a new name: nPulse™ Vybrance™. More than a name update, this change shows our commitment to paving the way for more groundbreaking advancements that will benefit practices and patients.

0:28
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·18 Sep 2025

Our team was honored to attend the American Thyroid Association (@AmThyroidAssn) Annual Meeting! We met many attendees at our booth and our Expo Theater presentation to discuss Nanosecond Pulsed Field Ablation (nsPFA™) technology and hope to meet even more of you next year.

0:12
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·5 Sep 2025

Our team is looking forward to attending the American Thyroid Association (@AmThyroidAssn) Annual Meeting in Scottsdale, Arizona next week. We hope to meet many of you at booth 315 and at our Expo Theater presentation on September 13. #atathyroid2025

0:22
Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·29 May 2025

Thank you to everyone who joined us at #HRS2025 in San Diego! Watch our live case below highlighting the nsPFA 360˚ Catheter’s ability to rapidly isolate the pulmonary veins with a fast, efficient workflow. We’re grateful to the Na Homolce Hospital team and Dr. Vivek Reddy, Dr. Petr Neuzil and Dr. Gregory Michaud for their collaboration and expertise on this case. Congratulations to Dr. Jan Petru and Dr. Moritoshi Funasako for a great live case: vimeo.com/1086559629 #EPeeps #nsPFA #PulseBiosciences CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.

Pulse Biosciences avatar
Pulse Biosciences@Pulse_Bio·28 May 2025

Congratulations to Dr. Thomas J. Fahey on successfully completing his first cases using Nanosecond Pulsed Field Ablation (nsPFA™) technology — and a big shout out to the entire team at Weill Cornell Medicine! We’re incredibly grateful for your partnership and dedication to advancing patient care. These cases also mark an exciting milestone: 100 “minimally invasive” nsPFA™ cases completed in the U.S.! We’re thrilled to celebrate this achievement with you and look forward to what’s ahead! #Healthcare #nsPFA #WeillCornellMedicine #PatientFirst

Post attachment